Rheumatoid arthritis trials recruiting in Texas

All Rheumatoid arthritis trials nationally

Cities in Texas

Recruiting trials in Texas

• A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
  NCT07123038 · Phase: Not specified · Ages: 18 Years to 71 Years · Sex: All (male and female) · Texas: Houston
• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
  NCT06747949 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Baytown, Colleyville, Katy, McAllen
• A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
  NCT06733935 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, Houston
• A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
  NCT06570798 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Houston
• A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
  NCT07737743 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Texas: Bellaire
• A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
  NCT07412704 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: DeSoto
• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
  NCT07041099 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Plano, Webster
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
  NCT07607964 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Red Oak
• A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
  NCT06977724 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Harlingen
• A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
  NCT07137598 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Colleyville, Houston, Tomball
• A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
  NCT07409103 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Baytown, Houston, Jackson, Red Oak
• A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
  NCT06972446 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Allen, Austin, Carrollton, Corpus Christi
• A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
  NCT07276581 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Baytown, Houston, Mesquite
• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
  NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Arlington, Bellaire, Irving, Katy
• An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
  NCT07620392 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston, Tomball
• ConsideRAte Study - Splenic Stimulation for RA
  NCT05003310 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · Texas: Allen, Austin, Dallas, Mesquite
• Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
  NCT02418442 · Phase: Not specified · Ages: Up to 21 Years · Sex: All (male and female) · Texas: Dallas, Houston
• Phase 1b/2 Study of IV Sarilumab in Adult With RA
  NCT07704580 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Plano
• Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
  NCT07404865 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Allen, Amarillo, Baytown, Bellaire
• R-2487 in Patients With Rheumatoid Arthritis
  NCT05961592 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Houston
• RA-PRO PRAGMATIC TRIAL
  NCT04692493 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Colleyville, Dallas, El Paso, Harlingen
• Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
  NCT07201558 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Allen, Mesquite
• Study of GS-0151 in Participants With Rheumatoid Arthritis
  NCT06902519 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Baytown, Colleyville, Houston, Irving
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Fort Worth, Houston, Richardson
• Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
  NCT04751396 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• The Myelin Disorders Biorepository Project
  NCT03047369 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Houston
• Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
  NCT07621809 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, Corpus Christi, Euless, Houston
• Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
  NCT07293871 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Colleyville, Dallas, Irving